Frontiers in Oncology Seminars

Potentials and Pitfalls for Use of Real-World Data to Inform Clinical Practice 

March 15, 2022 

Tarec Christoffer El-Galaly is a professor of hematology at Aalborg University Hospital, Denmark. His main clinical interest is in the treatment of lymphomas, in particular Hodgkin and aggressive non-Hodgkin lymphomas. His academic interest is in clinical epidemiology and real-world data analytics. Professor El-Galaly has led several national and international studies where real-world data has been utilized to inform clinical practice.

His research has been focused on using real-world data to improve clinical practice for staging, treatment, and post-treatment follow-up of lymphomas. A particular focus has been post-treatment surveillance and late toxicities as well as improving prognostic models for lymphoma by using real-world data and machine learning. The latter includes development of dynamic prognostic models.